CN Stock MarketDetailed Quotes

002252 Shanghai RAAS Blood Products

Watchlist
  • 7.96
  • 0.000.00%
Pre-Opening Auction Jul 2 09:30 CST
52.90BMarket Cap29.05P/E (TTM)

Shanghai RAAS Blood Products Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shanghai RAAS Blood Products Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

2.06B

-0.33%
EPS(YoY)

0.11

+6.54%
Analyst Rating

Strong Buy

Jul 1, 2024

Shanghai RAAS Blood Products Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 2.257B--
Aug 28, 20242024/Q2-- / 2.038B--
--2024/Q12.056B / 2.322B--
--2023/Q42.029B / 1.814B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 2.257B--
Aug 28, 20242024/Q2-- / 2.038B--
--2024/Q12.056B / 2.322B--
--2023/Q42.029B / 1.814B--

Shanghai RAAS Blood Products Earnings Reports

  • Shanghai RAAS Blood Products: 2024 First Quarter Report

    Apr 30 00:00

  • Shanghai RAAS Blood Products: 2023 ANNUAL REPORT

    Apr 29 00:00

  • Shanghai RAAS Blood Products: 2023 Annual Report Summary

    Apr 29 00:00

  • Shanghai Rexroth: 2023 Annual Results Forecast

    Jan 30 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 1, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg